SCHEMBL7436122

SCHEMBL7436122

CCc1cc(Cl)n2ncc(Cl)c2n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.38
ALDH1A1 P00352 3/20 0.38
MAPT P10636 2/20 0.38
RAB9A P51151 2/20 0.38
GSK3B P49841 1/20 0.37
CCNT1 O60563 3/20 0.36
CDK9 P50750 3/20 0.36
CDK2 P24941 4/20 0.35
CDK1 P06493 2/20 0.35
CDK4 P11802 2/20 0.35
CCNA2 P20248 2/20 0.35
CCND1 P24385 2/20 0.35
CCNE1 P24864 2/20 0.35
CDK7 P50613 2/20 0.35
CCNH P51946 2/20 0.35
CCNA1 P78396 2/20 0.35
CDK3 Q00526 2/20 0.35
CDK6 Q00534 2/20 0.35
CDK5 Q00535 2/20 0.35
CDK5R1 Q15078 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31465464 0.85 KDM4E (0.41) KDM4EALDH1A1MAPTRAB9AGSK3B
SCHEMBL7438391 0.85 CDK2 (0.40) KDM4EALDH1A1MAPTRAB9AGSK3B
SCHEMBL12953210 0.83 GSK3B (0.52) KDM4EALDH1A1MAPTRAB9AGSK3B
SCHEMBL31465431 0.83 KDM4E (0.40) KDM4EALDH1A1MAPTRAB9AGSK3B
SCHEMBL13304696 0.83 KDM4E (0.36) KDM4EALDH1A1MAPTRAB9AGSK3B
SCHEMBL7443554 0.81 KDM4E (0.35) KDM4EALDH1A1MAPTRAB9AGSK3B
SCHEMBL26871034 0.79 CCNT1 (0.33) KDM4EALDH1A1MAPTRAB9ACCNT1
SCHEMBL26871203 0.78 CCNT1 (0.36) KDM4EALDH1A1MAPTRAB9ACCNT1
SCHEMBL7447843 0.77 ALDH1A1 (0.41) KDM4EALDH1A1MAPTRAB9AGSK3B
SCHEMBL31465393 0.77 KDM4E (0.59) KDM4EALDH1A1MAPTRAB9ACCNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025068090-A1 COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF DISEASES GALAPAGOS NV (BE) 2025-04-03 WO disclosed
EP-0628559-B1 Pyrimidine compounds and their use as pharmaceuticals BEIERSDORF LILLY GMBH (DE) 2002-04-03 EP disclosed
US-5602136-A Pyrimidine compounds and their use as pharmaceuticals BEIERSDORF-LILLY GMBH (DE) 1997-02-11 US disclosed
US-5602137-A Pyrimidine compounds and their use as pharmaceuticals BEIERSDORF-LILLY GMBH (DE) 1997-02-11 US disclosed
US-5571813-A Fused pyrimidine compounds and their use as pharmaceuticals BEIERSDORF-LILLY GMBH (DE) 1996-11-05 US disclosed
EP-0628559-A1 Pyrimidine compounds and their use as pharmaceuticals Beiersdorf-Lilly GmbH (DE) 1994-12-14 EP disclosed